Logo image of CRBD

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) Stock Fundamental Analysis

NYSE:CRBD - New York Stock Exchange, Inc. - US21871X2080 - Currency: USD

23.2  -0.3 (-1.28%)

After market: 23.36 +0.16 (+0.69%)

Fundamental Rating

4

Overall CRBD gets a fundamental rating of 4 out of 10. We evaluated CRBD against 100 industry peers in the Financial Services industry. CRBD may be in some trouble as it scores bad on both profitability and health. CRBD may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CRBD was profitable.
In the past year CRBD had a positive cash flow from operations.
CRBD had positive earnings in each of the past 5 years.
Each year in the past 5 years CRBD had a positive operating cash flow.
CRBD Yearly Net Income VS EBIT VS OCF VS FCFCRBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

1.2 Ratios

CRBD's Return On Assets of 0.18% is on the low side compared to the rest of the industry. CRBD is outperformed by 70.00% of its industry peers.
The Return On Equity of CRBD (5.74%) is worse than 61.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.43%, CRBD is doing worse than 68.00% of the companies in the same industry.
CRBD had an Average Return On Invested Capital over the past 3 years of 1.08%. This is significantly below the industry average of 11.84%.
Industry RankSector Rank
ROA 0.18%
ROE 5.74%
ROIC 0.43%
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)1.08%
ROIC(5y)0.99%
CRBD Yearly ROA, ROE, ROICCRBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

CRBD has a Profit Margin of 4.41%. This is in the lower half of the industry: CRBD underperforms 62.00% of its industry peers.
CRBD's Profit Margin has improved in the last couple of years.
CRBD has a Operating Margin (13.53%) which is in line with its industry peers.
CRBD's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.53%
PM (TTM) 4.41%
GM N/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
CRBD Yearly Profit, Operating, Gross MarginsCRBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

2

2. Health

2.1 Basic Checks

CRBD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CRBD has less shares outstanding
CRBD has less shares outstanding than it did 5 years ago.
CRBD has a worse debt/assets ratio than last year.
CRBD Yearly Shares OutstandingCRBD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 200M 400M 600M
CRBD Yearly Total Debt VS Total AssetsCRBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

The Debt to FCF ratio of CRBD is 6.39, which is on the high side as it means it would take CRBD, 6.39 years of fcf income to pay off all of its debts.
CRBD has a Debt to FCF ratio (6.39) which is in line with its industry peers.
A Debt/Equity ratio of 1.03 is on the high side and indicates that CRBD has dependencies on debt financing.
CRBD has a Debt to Equity ratio of 1.03. This is comparable to the rest of the industry: CRBD outperforms 46.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 6.39
Altman-Z N/A
ROIC/WACC0.06
WACC7.46%
CRBD Yearly LT Debt VS Equity VS FCFCRBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CRBD Yearly Current Assets VS Current LiabilitesCRBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B 8B

5

3. Growth

3.1 Past

CRBD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.84%, which is quite good.
The Earnings Per Share has been growing by 115.54% on average over the past years. This is a very strong growth
Looking at the last year, CRBD shows a very negative growth in Revenue. The Revenue has decreased by -20.43% in the last year.
CRBD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.01% yearly.
EPS 1Y (TTM)15.84%
EPS 3Y-31.14%
EPS 5Y115.54%
EPS Q2Q%5.45%
Revenue 1Y (TTM)-20.43%
Revenue growth 3Y-7.04%
Revenue growth 5Y8.01%
Sales Q2Q%-15.62%

3.2 Future

Based on estimates for the next years, CRBD will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.37% on average per year.
CRBD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.76% yearly.
EPS Next Y5.05%
EPS Next 2Y9.82%
EPS Next 3Y10.79%
EPS Next 5Y11.37%
Revenue Next Year-1.65%
Revenue Next 2Y2.9%
Revenue Next 3Y2.66%
Revenue Next 5Y2.76%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CRBD Yearly Revenue VS EstimatesCRBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B 25B
CRBD Yearly EPS VS EstimatesCRBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2 4 6

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.73, the valuation of CRBD can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of CRBD indicates a rather cheap valuation: CRBD is cheaper than 93.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of CRBD to the average of the S&P500 Index (27.45), we can say CRBD is valued rather cheaply.
CRBD is valuated cheaply with a Price/Forward Earnings ratio of 3.97.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CRBD indicates a rather cheap valuation: CRBD is cheaper than 95.00% of the companies listed in the same industry.
CRBD is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 4.73
Fwd PE 3.97
CRBD Price Earnings VS Forward Price EarningsCRBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CRBD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CRBD is cheaper than 69.00% of the companies in the same industry.
CRBD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CRBD is cheaper than 92.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.62
EV/EBITDA 10.12
CRBD Per share dataCRBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

CRBD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.94
PEG (5Y)0.04
EPS Next 2Y9.82%
EPS Next 3Y10.79%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.74%, CRBD has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 4.97, CRBD pays a bit more dividend than its industry peers.
CRBD's Dividend Yield is comparable with the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 2.74%

5.2 History

CRBD is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

77.62% of the earnings are spent on dividend by CRBD. This is not a sustainable payout ratio.
DP77.62%
EPS Next 2Y9.82%
EPS Next 3Y10.79%
CRBD Yearly Income VS Free CF VS DividendCRBD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B
CRBD Dividend Payout.CRBD Dividend Payout, showing the Payout Ratio.CRBD Dividend Payout.PayoutRetained Earnings

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64

NYSE:CRBD (7/3/2025, 7:13:57 PM)

After market: 23.36 +0.16 (+0.69%)

23.2

-0.3 (-1.28%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)07-29 2025-07-29/bmo
Inst Owners90.71%
Inst Owner ChangeN/A
Ins Owners0.34%
Ins Owner ChangeN/A
Market Cap12.77B
Analysts78.1
Price Target25.77 (11.08%)
Short Float %0%
Short Ratio0.41
Dividend
Industry RankSector Rank
Dividend Yield 2.74%
Yearly Dividend0.92
Dividend Growth(5Y)N/A
DP77.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.1%
Min EPS beat(2)-0.44%
Max EPS beat(2)0.65%
EPS beat(4)3
Avg EPS beat(4)4.33%
Min EPS beat(4)-0.44%
Max EPS beat(4)15.87%
EPS beat(8)6
Avg EPS beat(8)4.1%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.39%
Min Revenue beat(2)-14.87%
Max Revenue beat(2)-11.92%
Revenue beat(4)0
Avg Revenue beat(4)-19.34%
Min Revenue beat(4)-28.97%
Max Revenue beat(4)-11.92%
Revenue beat(8)3
Avg Revenue beat(8)-10.31%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.71%
PT rev (3m)-9.98%
EPS NQ rev (1m)-0.45%
EPS NQ rev (3m)-8.29%
EPS NY rev (1m)0.03%
EPS NY rev (3m)-7.52%
Revenue NQ rev (1m)-0.59%
Revenue NQ rev (3m)-5.68%
Revenue NY rev (1m)-2.68%
Revenue NY rev (3m)-8.31%
Valuation
Industry RankSector Rank
PE 4.73
Fwd PE 3.97
P/S 0.82
P/FCF 6.62
P/OCF 6.62
P/B 1.07
P/tB 1.07
EV/EBITDA 10.12
EPS(TTM)4.9
EY21.12%
EPS(NY)5.84
Fwd EY25.16%
FCF(TTM)3.5
FCFY15.1%
OCF(TTM)3.5
OCFY15.1%
SpS28.38
BVpS21.77
TBVpS21.77
PEG (NY)0.94
PEG (5Y)0.04
Profitability
Industry RankSector Rank
ROA 0.18%
ROE 5.74%
ROCE 0.54%
ROIC 0.43%
ROICexc 0.43%
ROICexgc 0.62%
OM 13.53%
PM (TTM) 4.41%
GM N/A
FCFM 12.35%
ROA(3y)1.04%
ROA(5y)1.01%
ROE(3y)38.57%
ROE(5y)28.92%
ROIC(3y)1.08%
ROIC(5y)0.99%
ROICexc(3y)1.09%
ROICexc(5y)0.99%
ROICexgc(3y)1.62%
ROICexgc(5y)1.5%
ROCE(3y)1.38%
ROCE(5y)1.27%
ROICexcg growth 3Y-24.91%
ROICexcg growth 5YN/A
ROICexc growth 3Y-23.75%
ROICexc growth 5YN/A
OM growth 3Y-19.8%
OM growth 5Y24.34%
PM growth 3Y-27.73%
PM growth 5Y97.88%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 6.39
Debt/EBITDA 5.28
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 3.59
Cash Conversion 82.71%
Profit Quality 280.23%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC7.46%
ROIC/WACC0.06
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)144.44%
Profit Quality(5y)197%
High Growth Momentum
Growth
EPS 1Y (TTM)15.84%
EPS 3Y-31.14%
EPS 5Y115.54%
EPS Q2Q%5.45%
EPS Next Y5.05%
EPS Next 2Y9.82%
EPS Next 3Y10.79%
EPS Next 5Y11.37%
Revenue 1Y (TTM)-20.43%
Revenue growth 3Y-7.04%
Revenue growth 5Y8.01%
Sales Q2Q%-15.62%
Revenue Next Year-1.65%
Revenue Next 2Y2.9%
Revenue Next 3Y2.66%
Revenue Next 5Y2.76%
EBIT growth 1Y1.49%
EBIT growth 3Y-25.44%
EBIT growth 5Y34.3%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-35.71%
FCF growth 3Y-4.39%
FCF growth 5Y-2.53%
OCF growth 1Y-35.71%
OCF growth 3Y-4.39%
OCF growth 5Y-2.53%